Xylyx Bio Awarded $2.45M NIH SBIR Grant from NIDDK to Facilitate Development of Effective Drugs for Fibrotic Liver Disease
Award supports the development of a cell-based assay platform to help scientists discover and test drug candidates for liver fibrosis